{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:31Z","timestamp":1792783171831,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T00:00:00Z","timestamp":1452643200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Almirall","id":[{"id":"https:\/\/ror.org\/03qsven24","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00408-015-9839-y","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T05:37:16Z","timestamp":1452663436000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD"],"prefix":"10.1007","volume":"194","author":[{"given":"Arvind","family":"Manoharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"issue":"4","key":"9839_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347\u2013365","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"9839_CR2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pupt.2014.05.005","volume":"28","author":"A Gavalda","year":"2014","unstructured":"Gavalda A, Ramos I, Carcasona C et al (2014) The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide. Pulm Pharmacol Ther 28(2):114\u2013121","journal-title":"Pulm Pharmacol Ther"},{"issue":"7","key":"9839_CR3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/thx.2007.087213","volume":"63","author":"D Singh","year":"2008","unstructured":"Singh D, Brooks J, Hagan G, Cahn A, O\u2019Connor BJ (2008) Superiority of \u201ctriple\u201d therapy with salmeterol\/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax 63(7):592\u2013598","journal-title":"Thorax"},{"issue":"1","key":"9839_CR4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2011.09.002","volume":"106","author":"NA Hanania","year":"2012","unstructured":"Hanania NA, Crater GD, Morris AN, Emmett AH, O\u2019Dell DM, Niewoehner DE (2012) Benefits of adding fluticasone propionate\/salmeterol to tiotropium in moderate to severe COPD. Respir Med 106(1):91\u2013101","journal-title":"Respir Med"},{"issue":"3","key":"9839_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.rmed.2011.09.004","volume":"106","author":"KS Jung","year":"2012","unstructured":"Jung KS, Park HY, Park SY et al (2012) Comparison of tiotropium plus fluticasone propionate\/salmeterol with tiotropium in COPD: a randomized controlled study. Respir Med 106(3):382\u2013389","journal-title":"Respir Med"},{"issue":"8","key":"9839_CR6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1164\/rccm.200904-0492OC","volume":"180","author":"T Welte","year":"2009","unstructured":"Welte T, Miravitlles M, Hernandez P et al (2009) Efficacy and tolerability of budesonide\/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180(8):741\u2013750","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"9839_CR7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-146-8-200704170-00152","volume":"146","author":"SD Aaron","year":"2007","unstructured":"Aaron SD, Vandemheen KL, Fergusson D et al (2007) Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 146(8):545\u2013555","journal-title":"Ann Intern Med"},{"issue":"5","key":"9839_CR8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pupt.2006.06.001","volume":"20","author":"M Cazzola","year":"2007","unstructured":"Cazzola M, Ando F, Santus P et al (2007) A pilot study to assess the effects of combining fluticasone propionate\/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD. Pulm Pharmacol Ther 20(5):556\u2013561","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"9839_CR9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1378\/chest.10-0247","volume":"138","author":"PA Williamson","year":"2010","unstructured":"Williamson PA, Short PM, Clearie KL et al (2010) Paradoxical trough effects of triple therapy with budesonide\/formoterol and tiotropium bromide on pulmonary function outcomes in COPD. Chest 138(3):595\u2013604","journal-title":"Chest"},{"issue":"6","key":"9839_CR10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/thoraxjnl-2014-206670","volume":"70","author":"PA Frith","year":"2015","unstructured":"Frith PA, Thompson PJ, Ratnavadivel R et al (2015) Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol\/fluticasone in patients with COPD: the GLISTEN study-a randomised controlled trial. Thorax 70(6):519\u2013527","journal-title":"Thorax"},{"issue":"3","key":"9839_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1378\/chest.11-0406","volume":"141","author":"R Fuhr","year":"2012","unstructured":"Fuhr R, Magnussen H, Sarem K et al (2012) Efficacy of aclidinium bromide 400 \u03bcg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD. Chest 141(3):745\u2013752","journal-title":"Chest"},{"issue":"4","key":"9839_CR12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/15412555.2013.814626","volume":"10","author":"J Beier","year":"2013","unstructured":"Beier J, Kirsten AM, Mroz R et al (2013) Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study. COPD 10(4):511\u2013522","journal-title":"COPD"},{"issue":"2","key":"9839_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00408-010-9275-y","volume":"189","author":"PA Williamson","year":"2011","unstructured":"Williamson PA, Clearie K, Menzies D, Vaidyanathan S, Lipworth BJ (2011) Assessment of small-airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD. Lung 189(2):121\u2013129","journal-title":"Lung"},{"issue":"2","key":"9839_CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4997\/JRCPE.2012.204","volume":"42","author":"WJ Anderson","year":"2012","unstructured":"Anderson WJ, Lipworth BJ (2012) Relationships between impulse oscillometry, spirometry and dyspnoea in COPD. J R Coll Physicians Edinb 42(2):111\u2013115","journal-title":"J R Coll Physicians Edinb"},{"issue":"7","key":"9839_CR15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.rmed.2011.01.010","volume":"105","author":"C Crim","year":"2011","unstructured":"Crim C, Celli B, Edwards LD et al (2011) Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results. Respir Med 105(7):1069\u20131078","journal-title":"Respir Med"},{"issue":"2","key":"9839_CR16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","volume":"31","author":"M Cazzola","year":"2008","unstructured":"Cazzola M, MacNee W, Martinez FJ et al (2008) Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31(2):416\u2013469","journal-title":"Eur Respir J"},{"issue":"1","key":"9839_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1378\/chest.11-0038","volume":"141","author":"PM Short","year":"2012","unstructured":"Short PM, Williamson PA, Elder DH, Lipworth SI, Schembri S, Lipworth BJ (2012) The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting beta-agonist therapy in COPD. Chest 141(1):81\u201386","journal-title":"Chest"},{"issue":"2","key":"9839_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.apmr.2009.10.017","volume":"91","author":"AE Holland","year":"2010","unstructured":"Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF (2010) Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 91(2):221\u2013225","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"9839_CR19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1183\/09031936.00063810","volume":"37","author":"MA Puhan","year":"2011","unstructured":"Puhan MA, Chandra D, Mosenifar Z et al (2011) The minimal important difference of exercise tests in severe COPD. Eur Respir J 37(4):784\u2013790","journal-title":"Eur Respir J"},{"issue":"2","key":"9839_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","volume":"21","author":"TJ Witek Jr","year":"2003","unstructured":"Witek TJ Jr, Mahler DA (2003) Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 21(2):267\u2013272","journal-title":"Eur Respir J"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-015-9839-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-015-9839-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-015-9839-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T10:59:09Z","timestamp":1567508349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-015-9839-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9839"],"URL":"https:\/\/doi.org\/10.1007\/s00408-015-9839-y","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}